Epithalon 50mg

Research

Scientific Research on the Epitalon Peptide

Epitalon (also known as Epithalon) is a synthetic tetrapeptide composed of the amino acid sequence Alanine–Glutamic Acid–Aspartic Acid–Glycine (Ala‑Glu‑Asp‑Gly). The compound was developed and extensively studied by researchers at the St. Petersburg Institute of Bioregulation and Gerontology, Russia, within the context of aging and cellular longevity research.
Epitalon was designed to mimic epitalamine, a natural extract derived from the pineal gland, and has been investigated mainly for its potential geroprotective, circadian‑regulatory, and longevity‑modulating properties. Among the key features studied are:

• Potential anti‑aging effects
• Stimulation of telomerase activity
• Regulation of melatonin production and circadian rhythms
• Influence on immune function
• Modulation of gene expression associated with aging

Most available evidence comes from experimental studies conducted in Russia, involving cell‑culture models, animal experiments, and long‑term physiological observations.

Telomere dynamics and telomerase activity

Research indicates that Epitalon can activate telomerase in various cell types. Studies have shown increased expression of the catalytic subunit of telomerase, leading to elevated enzymatic activity and telomere elongation in human somatic cells.
This effect on telomeres suggests a potential mechanism by which Epitalon may delay cellular senescence. In experimental models, cells treated with the peptide showed maintained or increased telomere length and extended proliferative capacity, surpassing the Hayflick limit—the maximum number of divisions of somatic cells.

Longevity and anti‑aging effects

Several experimental studies have associated Epitalon with extended lifespan in different organisms. In mice, treatment resulted in approximately 13.3% higher life expectancy in the last surviving individuals and a 12.3% increase in maximum longevity. In Drosophila melanogaster, lifespan extension ranging from 11% to 16% was observed, even at extremely low concentrations.
Epitalon has also demonstrated:

• Reduction of telomere shortening
• Sustained increase in telomerase activity
• Decreased frequency of chromosomal aberrations, suggesting an antimutagenic effect

These factors contribute to the understanding of Epitalon as a potential geroprotective agent. In oocytes, Epitalon reduced production of reactive oxygen species (ROS) and improved mitochondrial function, mechanisms linked to delayed cellular aging. In aged primates, studies reported partial restoration of age‑related hormonal imbalances, including elevated melatonin levels and improved glucose metabolism.
Moreover, there is evidence that Epitalon influences the expression of genes related to aging, stress response, and cellular homeostasis, possibly via direct or indirect interactions with DNA.

Antioxidant properties

Epitalon has been shown to significantly reduce intracellular levels of reactive oxygen species (ROS), metabolic by‑products associated with oxidative stress and molecular damage. This reduction is linked to improved mitochondrial function and decreased apoptosis in aged cells.
Compared with melatonin in some settings, Epitalon appears to exhibit comparable or even superior antioxidant activity. In addition to direct free‑radical scavenging, the peptide seems to stimulate expression of endogenous antioxidant enzymes, thereby broadening its protective effect.

Tumor‑inhibitory effects and modulation of carcinogenesis

Epitalon has demonstrated relevant inhibitory effects in experimental cancer models. In HER‑2/neu transgenic mice, treatment with Epitalon significantly reduced:

• Cumulative number of mammary tumors
• Tumor size
• Incidence of multiple tumors

In rat models, Epitalon inhibited 1,2‑dimethylhydrazine (DMH)‑induced colorectal carcinogenesis, reducing both the number and size of tumors, particularly when administered during early stages of carcinogenesis.
These antitumor effects appear partly linked to reduced expression of oncogenes such as HER‑2/neu and to modulation of cellular pathways involved in proliferation and genomic stability.

Final considerations

Scientific research positions Epitalon as a peptide of high interest in the study of cellular aging, longevity, genomic stability, and circadian regulation. Its ability to modulate telomeres, reduce oxidative stress, and influence gene expression supports its value as an experimental tool in biogerontology and molecular biology.
Despite promising results in experimental models, Epitalon remains a research‑only compound. Additional rigorous, well‑controlled studies are needed to fully clarify its mechanisms, safety profile, and potential future applications, always within appropriate scientific and regulatory frameworks.

References

• Khavinson, V., Bondarev, I., & Butyugov, A. (2003). Epitalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bulletin of Experimental Biology and Medicine, 135, 590–592.
• Shi‑Liang, T. (2007). Retardation of cellular senescence by epitalon and changes in telomere length and telomerase activity. Journal of Chongqing University of Education.
• Anisimov, V., Khavinson, V., Popovich, I., et al. (2004). Effect of Epitalon on aging biomarkers, life span, and spontaneous tumor incidence in female SHR mice. Biogerontology, 4, 193–202.
• Khavinson, V., Izmaylov, D., Obukhova, L., & Malinin, V. (2000). Effect of epitalon on life span extension in Drosophila melanogaster. Mechanisms of Ageing and Development, 120, 141–149.
• Khavinson, V., Bondarev, I., Butyugov, A., & Smirnova, T. (2004). The peptide promotes overcoming the division limit in human somatic cells. Bulletin of Experimental Biology and Medicine, 137, 503–506.
• Rosenfeld, S., et al. (2002). Effect of epitalon on the incidence of chromosomal aberrations in accelerated‑senescence mice. Bulletin of Experimental Biology and Medicine, 133, 274–276.
• Yue, X., et al. (2022). Epitalon protects against post‑ovulatory aging‑related damage in mouse oocytes in vitro. Aging (Albany NY), 14, 3191–3202.
• Goncharova, N., et al. (2005). Pineal peptides restore age‑related disturbances in pineal and pancreatic hormonal functions. Experimental Gerontology, 40, 51–57.
• Khavinson, V., & Malinin, V. (2005). Gerontological aspects of genomic peptide regulation.
• Kozina, L., Arutjunyan, A., & Khavinson, V. (2007). Antioxidant properties of pineal geroprotective peptides. Archives of Gerontology and Geriatrics, 44 Suppl 1, 213–216.
• Anisimov, V., et al. (2002). Epitalon inhibits mammary tumor growth and HER‑2/neu oncogene expression in accelerated‑aging transgenic mice. Bulletin of Experimental Biology and Medicine, 133, 167–170.
• Anisimov, V., Khavinson, V., Popovich, I., & Zabezhinski, M. (2002). Inhibitory effect of the peptide Epitalon on 1,2‑dimethylhydrazine‑induced colon carcinogenesis in rats. Cancer Letters, 183(1), 1–8.

Scientific Reviewer

The content was reviewed by Dr. Ky H. Le, MD. Dr. Ky H. Le is a family physician in Aiea, Hawaii. He received his medical degree from St. George’s University School of Medicine and has practiced for over 20 years. He has expertise in the treatment of obesity, diabetes, hypertension, and high blood pressure, among other conditions. Dr. Ky H. Le accepts Medicare, Aetna, Humana, Blue Cross, and United Healthcare.

Ref.: https://health.usnews.com/doctors/ky-le-371599#expertise